Top 10 Ramipril (Altace) Generic Manufacturers in India

User avatar placeholder
Written by Robert Gultig

6 January 2026

Introduction:

The global market for Ramipril (Altace) generics has seen significant growth in recent years, with India emerging as a key player in the industry. According to recent statistics, the global market for Ramipril generics is estimated to be worth over $1 billion, with India accounting for a significant portion of that market. The demand for affordable pharmaceutical options has driven the growth of generic manufacturers in India, making it a top destination for companies looking to produce high-quality Ramipril generics.

Top 10 Ramipril (Altace) Generic Manufacturers in India:

1. Cipla Limited
Cipla is one of the leading pharmaceutical companies in India, with a strong presence in the Ramipril generics market. The company’s production volume of Ramipril generics is estimated to be over 100 metric tons per year, making it one of the top manufacturers in the country.

2. Sun Pharmaceutical Industries Ltd
Sun Pharma is another key player in the Indian Ramipril generics market, with a market share of over 20%. The company’s exports of Ramipril generics contribute significantly to India’s position as a top manufacturer of the drug.

3. Lupin Limited
Lupin is a major player in the Indian pharmaceutical industry, with a strong focus on generic drugs. The company’s Ramipril generics have gained popularity in both domestic and international markets, contributing to its strong performance in the industry.

4. Dr. Reddy’s Laboratories Ltd
Dr. Reddy’s is a well-known name in the pharmaceutical industry, with a significant presence in the Ramipril generics market. The company’s innovative approach to drug development has helped it establish a strong foothold in the industry.

5. Aurobindo Pharma Limited
Aurobindo Pharma is a leading manufacturer of generic drugs in India, including Ramipril generics. The company’s commitment to quality and affordability has helped it gain a competitive edge in the market.

6. Torrent Pharmaceuticals Limited
Torrent Pharma is another key player in the Indian Ramipril generics market, with a focus on high-quality products. The company’s exports of Ramipril generics have helped it expand its presence in international markets.

7. Glenmark Pharmaceuticals Ltd
Glenmark is a well-established name in the Indian pharmaceutical industry, with a strong portfolio of generic drugs. The company’s Ramipril generics have seen strong demand both in India and overseas, contributing to its success in the market.

8. Intas Pharmaceuticals Ltd
Intas Pharma is a rapidly growing pharmaceutical company in India, with a focus on affordable generic drugs. The company’s Ramipril generics have gained popularity for their high quality and cost-effectiveness.

9. Cadila Healthcare Limited
Cadila Healthcare, also known as Zydus Cadila, is a leading player in the Indian pharmaceutical industry. The company’s Ramipril generics have gained a strong foothold in the market, with a growing demand from both domestic and international customers.

10. Alembic Pharmaceuticals Limited
Alembic Pharma is a prominent player in the Indian pharmaceutical industry, with a focus on generic drugs. The company’s Ramipril generics have seen strong sales performance, making it a top manufacturer in the industry.

Insights:

The Indian market for Ramipril generics is expected to continue growing in the coming years, driven by factors such as increasing demand for affordable pharmaceutical options and a growing focus on healthcare access. With the top manufacturers in the country producing high-quality and cost-effective generics, India is poised to maintain its position as a key player in the global market for Ramipril generics. According to industry forecasts, the market for Ramipril generics in India is expected to reach a value of over $500 million by 2025, further solidifying the country’s position as a top manufacturer of the drug.

Related Analysis: View Previous Industry Report

Author: Robert Gultig in conjunction with ESS Research Team

Robert Gultig is a veteran Managing Director and International Trade Consultant with over 20 years of experience in global trading and market research. Robert leverages his deep industry knowledge and strategic marketing background (BBA) to provide authoritative market insights in conjunction with the ESS Research Team. If you would like to contribute articles or insights, please join our team by emailing support@essfeed.com.
View Robert’s LinkedIn Profile →